drugset / Trial / NCT01902121

Compare the Same Dosage of Insulin Using a Combination of Cartridges, 30 Units as 2 Cartridges vs. 1 Cartridge

NCT01902121

Phase 1 Completed 40 enrolled Mannkind Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

A Phase 1, open-label, randomized, crossover study in 36 healthy normal volunteers (HNVs) to evaluate the bioequivalence of TI Inhalation Powder delivered using the Gen2 Inhaler and administered as one 30 U cartridge versus a combination of one 10 U cartridge and one 20 U cartridge.

Timeline

Start
2013-08
Primary completion
2013-11
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 30 iu Inhaled

Indications

No indication recorded.